Clinical Trials Directory

Trials / Terminated

TerminatedNCT04198649

Effect of Azithromycin on Failure Proportion of Severe Periodontitis Non-surgical Treatment

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
6 (actual)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Not accepted

Summary

Primary purpose: Evaluate the effect of azithromycin on failure proportion of severe chronic periodontitis non-surgical treatment; failure characterized by the persistence of at least one periodontal pocket\> 5mm at 6 months Secondary purpose: * Evaluate the effect of azithromycin on the persistence of pathological periodontal pockets \> 5mm during non-surgical treatment of severe chronic periodontitis at 3 months and 6 months * Evaluate the effect of azithromycin on the changes of clinical signs, periopathogen levels, expression of macrolides resistance genes, and expression of antimicrobial peptides (PAMs) during treatment of severe chronic periodontitis at 3 months and 6 months * Assess therapeutic observance and side effects of antibiotic treatment * Assess at 3 and 6 months the potential interactions of local, bacterial (periopathogen and resistance gene) clinical factors, and host defense (PAMs) with the effect of azithromycin, on failure proportion of severe chronic periodontitis non-surgical treatment

Conditions

Interventions

TypeNameDescription
DRUGNon-surgical periodontal treatment and azithromycin treatmentProcedure: periodontal treatment: oral hygiene instruction, scaling and root planning Drug: two 250mg azithromycin tablets one time daily for 3 days after scaling and root planning sessions
OTHERNon-surgical periodontal treatment and placebo treatmentProcedure: periodontal treatment: oral hygiene instruction, scaling and root planning Placebo: two 250mg starch tablets one time daily for 3 days after scaling and root planning sessions

Timeline

Start date
2021-11-02
Primary completion
2023-11-02
Completion
2023-11-02
First posted
2019-12-13
Last updated
2024-08-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04198649. Inclusion in this directory is not an endorsement.